Walleye Capital LLC Ibere Pharmaceuticals Call Options Transaction History
Walleye Capital LLC
- $46.2 Billion
- Q3 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding IBER
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About IBERE PHARMACEUTICALS
- Ticker IBER
- Exchange NYSE
- Sector Financial Services
- Industry Shell Companies
- Shares Outstandng 13,800,000
- Description
- Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.